NCT06730659View on ClinicalTrials.gov

A Clinical Study of CHT101 in CD70-Positive Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 19, 2024

Primary Completion Date

April 18, 2027

Study Completion Date

April 18, 2039

Conditions
Relapsed / Refractory Solid Tumor
Interventions
BIOLOGICAL

CHT101

CHT101: CD 70 UCAR T

Trial Locations (1)

Unknown

RECRUITING

Tianjin Medical University Cancer Institute and Hospital, Tianjin

All Listed Sponsors
collaborator

Nanjing Calmhome Cell and Gene Engineering Institute Co., Ltd.

INDUSTRY

lead

Tianjin Medical University Cancer Institute and Hospital

OTHER